Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05903833 |
| Title | Pembrolizumab in Combination With Lenvatinib in Pts With Recurrent, Persistent, Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy (PIERCE) |
| Acronym | PIERCE |
| Recruitment | Not yet recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | AGO Research GmbH |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DEU |